“The current circumstance has uncovered some structural weaknesses during the EU’s medicines source chain in addition to a higher dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides stated. She advisable that supply chain issues be resolved within an EU pharmaceutical str… Read More